Cargando…

Unravelling the potential of social prescribing in individual-level type 2 diabetes prevention: a mixed-methods realist evaluation

BACKGROUND: Social prescribing (SP) usually involves linking patients in primary care with services provided by the voluntary and community sector. Preliminary evidence suggests that SP may offer a means of connecting patients with community-based health promotion activities, potentially contributin...

Descripción completa

Detalles Bibliográficos
Autores principales: Calderón-Larrañaga, Sara, Greenhalgh, Trish, Clinch, Megan, Robson, John, Dostal, Isabel, Eto, Fabiola, Finer, Sarah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10008720/
https://www.ncbi.nlm.nih.gov/pubmed/36907857
http://dx.doi.org/10.1186/s12916-023-02796-9
_version_ 1784905821164929024
author Calderón-Larrañaga, Sara
Greenhalgh, Trish
Clinch, Megan
Robson, John
Dostal, Isabel
Eto, Fabiola
Finer, Sarah
author_facet Calderón-Larrañaga, Sara
Greenhalgh, Trish
Clinch, Megan
Robson, John
Dostal, Isabel
Eto, Fabiola
Finer, Sarah
author_sort Calderón-Larrañaga, Sara
collection PubMed
description BACKGROUND: Social prescribing (SP) usually involves linking patients in primary care with services provided by the voluntary and community sector. Preliminary evidence suggests that SP may offer a means of connecting patients with community-based health promotion activities, potentially contributing to the prevention of long-term conditions, such as type 2 diabetes (T2D). METHODS: Using mixed-methods realist evaluation, we explored the possible contribution of SP to individual-level prevention of T2D in a multi-ethnic, socio-economically deprived population in London, UK. We made comparisons with an existing prevention programme (NHS Diabetes Prevention Programme (NDPP)) where relevant and possible. Anonymised primary care electronic health record data of 447,360 people 18+ with an active GP registration between December 2016 and February 2022 were analysed using quantitative methods. Qualitative data (interviews with 11 primary care clinicians, 11 social prescribers, 13 community organisations and 8 SP users at high risk of T2D; 36 hours of ethnographic observations of SP and NDPP sessions; and relevant documents) were analysed thematically. Data were integrated using visual means and realist methods. RESULTS: People at high risk of T2D were four times more likely to be referred into SP than the eligible general population (RR 4.31 (95% CI 4.17–4.46)), with adjustment for socio-demographic variables resulting in attenuation (RR 1.33 (95% CI 1.27–1.39)). More people at risk of T2D were referred to SP than to NDPP, which could be explained by the broad referral criteria for SP and highly supportive (proactive, welcoming) environments. Holistic and sustained SP allowed acknowledgement of patients’ wider socio-economic constraints and provision of long-term personalised care. The fact that SP was embedded within the local community and primary care infrastructure facilitated the timely exchange of information and cross-referrals across providers, resulting in enhanced service responsiveness. CONCLUSIONS: Our study suggests that SP may offer an opportunity for individual-level T2D prevention to shift away from standardised, targeted and short-term strategies to approaches that are increasingly personalised, inclusive and long-term. Primary care-based SP seems most ideally placed to deliver such approaches where practitioners, providers and commissioners work collectively to achieve holistic, accessible, sustained and integrated services. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12916-023-02796-9.
format Online
Article
Text
id pubmed-10008720
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-100087202023-03-13 Unravelling the potential of social prescribing in individual-level type 2 diabetes prevention: a mixed-methods realist evaluation Calderón-Larrañaga, Sara Greenhalgh, Trish Clinch, Megan Robson, John Dostal, Isabel Eto, Fabiola Finer, Sarah BMC Med Research Article BACKGROUND: Social prescribing (SP) usually involves linking patients in primary care with services provided by the voluntary and community sector. Preliminary evidence suggests that SP may offer a means of connecting patients with community-based health promotion activities, potentially contributing to the prevention of long-term conditions, such as type 2 diabetes (T2D). METHODS: Using mixed-methods realist evaluation, we explored the possible contribution of SP to individual-level prevention of T2D in a multi-ethnic, socio-economically deprived population in London, UK. We made comparisons with an existing prevention programme (NHS Diabetes Prevention Programme (NDPP)) where relevant and possible. Anonymised primary care electronic health record data of 447,360 people 18+ with an active GP registration between December 2016 and February 2022 were analysed using quantitative methods. Qualitative data (interviews with 11 primary care clinicians, 11 social prescribers, 13 community organisations and 8 SP users at high risk of T2D; 36 hours of ethnographic observations of SP and NDPP sessions; and relevant documents) were analysed thematically. Data were integrated using visual means and realist methods. RESULTS: People at high risk of T2D were four times more likely to be referred into SP than the eligible general population (RR 4.31 (95% CI 4.17–4.46)), with adjustment for socio-demographic variables resulting in attenuation (RR 1.33 (95% CI 1.27–1.39)). More people at risk of T2D were referred to SP than to NDPP, which could be explained by the broad referral criteria for SP and highly supportive (proactive, welcoming) environments. Holistic and sustained SP allowed acknowledgement of patients’ wider socio-economic constraints and provision of long-term personalised care. The fact that SP was embedded within the local community and primary care infrastructure facilitated the timely exchange of information and cross-referrals across providers, resulting in enhanced service responsiveness. CONCLUSIONS: Our study suggests that SP may offer an opportunity for individual-level T2D prevention to shift away from standardised, targeted and short-term strategies to approaches that are increasingly personalised, inclusive and long-term. Primary care-based SP seems most ideally placed to deliver such approaches where practitioners, providers and commissioners work collectively to achieve holistic, accessible, sustained and integrated services. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12916-023-02796-9. BioMed Central 2023-03-13 /pmc/articles/PMC10008720/ /pubmed/36907857 http://dx.doi.org/10.1186/s12916-023-02796-9 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Calderón-Larrañaga, Sara
Greenhalgh, Trish
Clinch, Megan
Robson, John
Dostal, Isabel
Eto, Fabiola
Finer, Sarah
Unravelling the potential of social prescribing in individual-level type 2 diabetes prevention: a mixed-methods realist evaluation
title Unravelling the potential of social prescribing in individual-level type 2 diabetes prevention: a mixed-methods realist evaluation
title_full Unravelling the potential of social prescribing in individual-level type 2 diabetes prevention: a mixed-methods realist evaluation
title_fullStr Unravelling the potential of social prescribing in individual-level type 2 diabetes prevention: a mixed-methods realist evaluation
title_full_unstemmed Unravelling the potential of social prescribing in individual-level type 2 diabetes prevention: a mixed-methods realist evaluation
title_short Unravelling the potential of social prescribing in individual-level type 2 diabetes prevention: a mixed-methods realist evaluation
title_sort unravelling the potential of social prescribing in individual-level type 2 diabetes prevention: a mixed-methods realist evaluation
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10008720/
https://www.ncbi.nlm.nih.gov/pubmed/36907857
http://dx.doi.org/10.1186/s12916-023-02796-9
work_keys_str_mv AT calderonlarranagasara unravellingthepotentialofsocialprescribinginindividualleveltype2diabetespreventionamixedmethodsrealistevaluation
AT greenhalghtrish unravellingthepotentialofsocialprescribinginindividualleveltype2diabetespreventionamixedmethodsrealistevaluation
AT clinchmegan unravellingthepotentialofsocialprescribinginindividualleveltype2diabetespreventionamixedmethodsrealistevaluation
AT robsonjohn unravellingthepotentialofsocialprescribinginindividualleveltype2diabetespreventionamixedmethodsrealistevaluation
AT dostalisabel unravellingthepotentialofsocialprescribinginindividualleveltype2diabetespreventionamixedmethodsrealistevaluation
AT etofabiola unravellingthepotentialofsocialprescribinginindividualleveltype2diabetespreventionamixedmethodsrealistevaluation
AT finersarah unravellingthepotentialofsocialprescribinginindividualleveltype2diabetespreventionamixedmethodsrealistevaluation